Guven, D. C. Et Al. 2024. The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study. Cancer Medicine , vol.13, no.1 .

Guven, D. C., Aykan, M. B., MUĞLU, H., BAYRAM, E., Helvaci, K., DURSUN, B., ... Celayir, M.(2024). The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study. Cancer Medicine , vol.13, no.1.

Guven, DENİZ Et Al. "The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study," Cancer Medicine , vol.13, no.1, 2024

Guven, DENİZ C. Et Al. "The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study." Cancer Medicine , vol.13, no.1, 2024

Guven, D. C. Et Al. (2024) . "The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study." Cancer Medicine , vol.13, no.1.

@article{article, author={DENİZ CAN GÜVEN Et Al. }, title={The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study}, journal={Cancer Medicine}, year=2024}